Literature DB >> 19006047

[Endothelial dysfunction: pathophysiology, diagnosis and prognosis].

T Münzel1.   

Abstract

The endothelium plays a crucial role in the regulation of vascular tone. Recent studies have indicated that endothelial dysfunction develops in the presence of cardiovascular risk factors such as hypertension, diabetes mellitus, hypercholesterolemia and in chronic smokers, as well as in patients with a family history of cardiovascular disease. It has now been established that endothelial dysfunction represents the first indicator of vascular damage. Endothelial function can be assessed in coronary and peripheral conductance and resistance vessels by means of invasive and noninvasive (ultrasound-guided) methods such as intracoronary infusion of acetylcholine, the endothelium-dependent vasodilator. It is interesting that endothelial dysfunction in the presence of cardiovascular risk factors can be almost completely corrected by the acute administration of antioxidants such as vitamin C, pointing to a crucial role of reactive oxygen species in mediating this phenomenon. Superoxide producing enzymes involved in the increased production of reactive oxygen species include NADPH oxidase, nitric oxide synthase in the uncoupled state, mitochondrial superoxide sources, cyclooxygenase and xanthine oxidase. Recent studies indicate that the endothelial dysfunction found in coronary and peripheral conductance and resistance vessels provide prognostic information about future cardiovascular events. The role of endothelial dysfunction in the setting of primary prevention is not yet clear, but is being investigated in the current Gutenberg Heart Study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19006047     DOI: 10.1055/s-0028-1100941

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  6 in total

1.  Sildenafil and FDP-Sr attenuate diabetic cardiomyopathy by suppressing abnormal expression of myocardial CASQ2, FKBP12.6, and SERCA2a in rats.

Authors:  Yu-si Cheng; De-zai Dai; Hui Ji; Qi Zhang; Yin Dai
Journal:  Acta Pharmacol Sin       Date:  2011-03-28       Impact factor: 6.150

2.  Variation of endothelial function during the menstrual cycle evaluated by flow-mediated dilatation of brachial artery.

Authors:  Augusto H F Brandão; Paula J Serra; Karla Zanolla; Antônio C V Cabral; Selmo Geber
Journal:  JBRA Assist Reprod       Date:  2014-12-27

Review 3.  Targeting vascular (endothelial) dysfunction.

Authors:  Andreas Daiber; Sebastian Steven; Alina Weber; Vladimir V Shuvaev; Vladimir R Muzykantov; Ismail Laher; Huige Li; Santiago Lamas; Thomas Münzel
Journal:  Br J Pharmacol       Date:  2016-07-04       Impact factor: 8.739

4.  Work-life conflict and cardiovascular health: 5-year follow-up of the Gutenberg Health Study.

Authors:  Janice Hegewald; Karla Romero Starke; Susan Garthus-Niegel; Andreas Schulz; Matthias Nübling; Ute Latza; Sylvia Jankowiak; Falk Liebers; Karin Rossnagel; Merle Riechmann-Wolf; Stephan Letzel; Natalie Arnold; Manfred Beutel; Emilio Gianicolo; Norbert Pfeiffer; Karl Lackner; Thomas Münzel; Philipp Wild; Andreas Seidler
Journal:  PLoS One       Date:  2021-05-07       Impact factor: 3.240

Review 5.  Transportation noise pollution and cardiovascular disease.

Authors:  Thomas Münzel; Mette Sørensen; Andreas Daiber
Journal:  Nat Rev Cardiol       Date:  2021-03-31       Impact factor: 32.419

Review 6.  Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension.

Authors:  Wolfgang Kreisel; Denise Schaffner; Adhara Lazaro; Jonel Trebicka; Irmgard Merfort; Annette Schmitt-Graeff; Peter Deibert
Journal:  Int J Mol Sci       Date:  2020-08-28       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.